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ABSTRACT
Leptin is a cytokine secreted from adipose tissue at a
rate commensurate with the size of the body’s fat
stores. In addition to its anorectic and thermogenic
central actions, leptin is known to act on peripheral
tissues, including the pancreatic â-cell where it
inhibits insulin secretion and reduces insulin
transcript levels. However, the role of leptin
signalling through its full-length receptor, OB-Rb,
in the â-cell remains unclear. In the present study,
we show that leptin activates a signal transducer and
activator of transcription (STAT)3 signalling mech-
anism in pancreatic islets and in a rat model of the
pancreatic â-cell, RINm5F. Leptin induced DNA
binding to a STAT consensus oligonucleotide and
resulted in transcriptional activation from STAT
reporter constructs in a manner consistent with
STAT3 activation. Western blot analysis confirmed
activation of STAT3 in RINm5F and isolated rat
islets. Conditions that mimic increased metabolic
activity resulted in attenuation of leptin-mediated
STAT DNA binding but had no significant eVect
on STAT3 tyrosine phosphorylation in RINm5F
cells. In addition, leptin activated the mitogen
activated protein (MAP) kinase pathway in
RINm5F cells. The present study provides a
framework for OB-Rb signalling mechanisms in the
programming of the â-cell by leptin and suggests
that increased metabolic activity may modulate this
function.
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INTRODUCTION
Leptin, a hormone secreted from white adipose
tissue (Zhang et al. 1994) in direct relation to the
size of total fat mass (MaVei et al. 1995), regulates
body weight homeostasis through anorectic and
thermogenic mechanisms (Campfield et al. 1995,
Pelleymounter et al. 1995). In addition, it has now
been demonstrated in many laboratories that leptin
inhibits insulin secretion from mouse, rat and
human pancreatic islets (Chen et al. 1997, Emilsson
et al. 1997, Fehmann et al. 1997a, KieVer et al.
1997, Kulkarni et al. 1997, Pallett et al. 1997,
Ookooma et al. 1998, Poitout et al. 1998).
Furthermore, leptin reduces insulin transcript levels
in rat islets (Kulkarni et al. 1997, Pallett et al. 1997).
The possible importance of leptin in control of
â-cell function in vivo is underlined by the fact that
leptin- and functional leptin receptor-deficient
mice (ob/ob and db/db respectively) exhibit early
onset hyperinsulinaemia, obesity and non-insulin-
dependent diabetes mellitus (NIDDM) (Coleman
1978, Zhang et al. 1994, Chen et al. 1996). Chronic
daily leptin administration to ob/ob mice leads to a
reduction in plasma insulin and glucose levels too
rapidly to be accounted for by the changes in body
weight (Campfield et al. 1995, Halaas et al. 1995,
Pelleymounter et al. 1995). Moreover, it has been
demonstrated that a single injection of leptin into
ob/ob and normal-fed mice produces an acute
reduction in plasma insulin levels, indicative of a
direct action on the â-cell (Kulkarni et al. 1997).
These findings have led us and others to postulate
that the high levels of leptin that occur in obese
individuals may exert an inappropriate inhibitory
action on â-cell insulin secretion and contribute to
the development of NIDDM (Emilsson et al. 1997,
Kulkarni et al. 1997, Pallett et al. 1997).
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Several recent studies have addressed the mech-
anism whereby leptin exerts its inhibitory action on
â-cells. Thus there is evidence to suggest that leptin
can hyperpolarize the â-cell by directly acting on
the ATP-sensitive potassium channels (Harvey
et al. 1997, KieVer et al. 1997). Leptin also lowers
the intracellular free calcium concentration ([Ca2+]i)
(Fehmann et al. 1997a,b, KieVer et al. 1997) and
chronic exposure to leptin results in intra-islet
triglyceride depletion, thus rendering the â-cell
unresponsive to nutrients (Koyama et al. 1997,
Shimabukuro et al. 1997, Wang et al. 1998). The
combined action of leptin on cellular membrane
potential, [Ca2+]i and triglyceride stores could
explain the observed acute inhibitory eVects of
leptin on insulin secretion and the longer-term
reduction in insulin transcript levels. Although
leptin has been shown to act through its full-length
receptor, OB-Rb, to activate the Janus kinase (JAK)
and signal transducer and activator of transcription
(STAT) pathway in a number of systems (Baumann
et al. 1996, Ghilardi et al. 1996), OB-Rb signalling
in pancreatic islets has not been defined. In the
present study we present evidence that the eVects of
leptin are mediated by a STAT3 mechanism in
primary rat islets and through STAT3 and mitogen
activated protein (MAP) kinase in RINm5F â-cells.
MATERIALS AND METHODS
Cell culture
RINm5F cells were a gift from Dr S Islam (Rolf Luft
Centre, Karolinska Institute, Stockholm, Sweden).
Cells were routinely cultured in 25 cm2 flasks
in RPMI-1640 medium (Gibco BRL, Paisley,
Strathclyde, UK) supplemented with 100 U/ml
penicillin, 100 µg/ml streptomycin, 2 mM l-
glutamine, 5·6 mM glucose and 10% fetal calf serum
at 5% CO2 in a humidified 37 )C cabinet. Flasks were
pre-incubated for a minimum of 24 h in serum-
free (0·1% BSA) RPMI-1640 before exposure to
recombinant murine leptin (Peprotech, London,
UK), forskolin/3-isobutyl-1-methylxanthine (IBMX),
acetylcholine or ionomycin (all from Alexis Corp.,
Nottingham, UK) for the indicated times and
concentrations in serum-free RPMI-1640. Serum-
free pre-incubation was necessary to reduce basal
STAT3 activation and to remove activity of residual
leptin present in the routine culture medium, as
described previously (Islam et al. 1997).
Nuclear extracts
After treatment, the cells were washed in ice-cold
PBS, and then in ice-cold PBS with phosphatase
inhibitors (1 mM Na3VO4, 5 mM NaF). Cells were
lysed in a hypotonic buVer (20 mM Hepes, pH 7·9,
20 mM NaF, 1 mM EDTA, 1 mM EGTA, 10 mM
Na2MoO4, 1 µM microcystin LR (Alexis Corp.)
with protease inhibitors (Boehringer Mannheim
Complete Mini Protease Pellets, Boehringer
Mannheim, Mannheim, Germany) and 0·2%
IGEPAL detergent (Sigma Chemical Co., Poole,
Dorset, UK). Nuclei were collected by brief
centrifugation at 14 000 g and the pellet re-
suspended in a high-salt buVer (hypotonic buVer
with 0·42 M NaCl and 20% glycerol, without
IGEPAL). Nuclear proteins were extracted for
30 min at 4 )C by rotation before sedimentation
of debris at 14 000 g for 20 min. Nuclear extract
supernatants were snap-frozen in liquid nitrogen
and stored at "80 )C before we undertook gel-shift
assays. A kit was used to determine protein
concentration, according to the manufacturer’s data
sheet (Sigma Diagnostics P5656 Protein Assay).
Isolation of islets and islet nuclear extracts
Pancreatic islets were isolated from male Wistar rats
of 200–250 g (Harlan Olac, Bicester, Oxon, UK) by
collagenase (Sigma type XI) digestion of pancreata
in a physiological saline solution as described
previously (Pallett et al. 1997). Groups of 200–500
islets were washed in RPMI-1640, 0·1% BSA and
incubated for 6 h. Islets were then collected and
re-suspended in RPMI-1640, 0·1% BSA with or
without leptin. After the incubation, islets were
collected by brief centrifugation and put on ice.
Five hundred microlitres ice-cold hypotonic
buVer (10 mM Hepes pH 7·9, 10 mM KCl, 1 mM
EDTA, 1 mM EGTA, 1 mM dithiothreitol
(DTT), 10 mM NaF, 10 mM Na2MoO4, 10 mM
â-glycerophosphate, 10 mM Na3VO4, 10 mM
p-nitrophenylphosphate, 1 µM microcystin LR) and
one tablet per 10 ml Complete Mini Protease
Inhibitor (Boehringer Mannheim) were added to
the islets on ice. After 15 min, 25 µl 10% IGEPAL
were added and the islets vortexed briefly. Nuclei
were collected by centrifugation at 14 000 g for 20 s
and the pellet re-suspended in 50 µl high-salt buVer
(hypotonic buVer with 0·4 M NaCl and 5% glycerol)
and one tablet per 10 ml Complete Mini Protease
Inhibitor. Debris was removed by centrifugation at
14 000 g for 10 min and the supernatant extracts
taken for gel-shift.
Mobility-shift assay
The gel-shift assay was performed with oligonucleo-
tides from the c-fos promoter (a mutated c-sis
inducible element, m67SIE) top strand 5*-CAT
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TTC CCG TAA ATC AT-3* and rat â-casein pro-
moter, top strand 5*-GGA CTT CTT GGA ATT
AAG GGA-3*. STAT-binding elements are under-
lined. These were end-labelled with [ª-32P]ATP
(Amersham, Little Chalfont, Bucks, UK) and T4
polynucleotide kinase (Gibco). Binding reactions
included 1 mM DTT, 1 µg/ml polydI:polydC
(Pharmacia, Uppsala, Sweden), 10% glycerol and
10 mM Tris, pH 7·9. The mixture was incubated at
room temperature for 20 min and protein–DNA
complexes were separated on 4% native polyacryl-
amide gels containing 5% glycerol. Gels were dried
under vacuum for 40 min and then exposed to Kodak
Biomax film (Sigma) at "80 )C overnight.
Western blot
Nuclear extracts were obtained as described above.
An equal volume of 2#sample-loading buVer
(100 mM Tris, pH 6·8, 10% SDS, 20% glycerol, 2%
â-mercaptoethanol, 0·2% bromophenol blue) was
added to the extracts and the samples boiled for
3 min. Samples were separated on 10% SDS-PAGE
gels and transferred to polyvinylidene fluoride
(PVDF) membranes (Millipore, Bedford, MA,
USA). Antibodies used were STAT3 N-terminal
specific (S21320, Transduction Labs, Lexington,
KY, USA), anti-phospho-STAT3 Y705 and anti-
phospho-MAP kinase Y204 (9131S, New England
Biolabs, Hitchin, Herts, UK).
Constructs and transcriptional reporter assays
Chloramphenicol acetyl transferase (CAT) reporter
constructs were used. These were: GAS-CAT,
containing four copies of the human FcªRI
interferon-ª activated sequence, GAS (5*-AGC
TTG AGA TGT ATT TCC CAG AAA AGA-3*),
IRE-CAT, containing four copies of the human
intercellular adhesion molecule-1 (ICAM-1)
interferon-ª/interleukin-6 response element, IRE
(5*-AGC TTA GTT TCC GGG AAA GCA C-3*),
and â-casein-CAT, containing four copies of the
â-casein STAT-binding site, â-CAS (5*-AGC TTA
GAT T TC TAG GAA TTC AAA TCA-3*).
STAT-binding sites were cloned into the thymidine
kinase (TK)-CAT vector pBLCAT2 using a
method described previously (Caldenhoven et al.
1996). For transfection experiments, cells were split
1:3 and 24 h later transfected with 10 µg supercoiled
plasmid DNA by the DEAE-dextran technique.
Briefly, DNA precipitates were prepared by mixing
the DNA with 1 ml of 0·5 mg/ml DEAE-dextran
solution (Pharmacia) in Tris-buVered saline (TBS).
Cells were washed twice with TBS, after which the
cells were exposed to the DNA precipitate for
30 min at room temperature. After washing the cells
twice with TBS, medium was added with 0·1 mM
chloroquine, and the cells were incubated for 6 h at
37 )C. Cells were then washed twice with PBS, and
fresh medium was added. Twenty-four hours later
cells were serum starved for 16 h, after which they
were stimulated for 12 h with leptin or vehicle and
subsequently harvested for CAT assay. Cells were
lysed by repeated freeze thawing in 250 mM Tris,
pH 7·4, 25 mM EDTA. Fifty microlitres of cellular
extract were then incubated in a total volume of
100 µl containing 250 mM Tris, pH 7·4, 2%
glycerol, 0·3 mM butyryl coenzyme A and 0·05 µCi
[14C]chloramphenicol for 2 h at 37 )C. Reaction
products were then extracted using 400 µl xylene:
pristane (1:2) and the percentage of acetylated
products determined using liquid scintillation
counting.
RESULTS
Leptin induces STAT DNA binding in nuclear
extracts from RINm5F and isolated rat islets
Leptin treatment of RINm5F cells caused induction
of a single STAT DNA binding complex with the
m67SIE oligonucleotide (Fig. 1). This probe
contains a mutated STAT-binding site from the
human c-fos promoter and has a high aYnity for
STAT3 and STAT1. Induction was apparent in
RINm5F nuclear extracts by 15 min and continued
to increase up to the 30 min time point. In
experiments using nuclear extracts from isolated rat
pancreatic islets, leptin induced a single STAT
DNA binding complex using the m67SIE probe
that was dose dependent over the concentration
range 0·2-20 nM (Fig. 2, left panel) in a 15 min
incubation. Time course studies in pancreatic islets
showed that induction of this single complex was
observed by 2 min, peaked by 15 min and returned
to basal levels by 30 min (Fig. 2, right panel).
Leptin induces STAT3 activation in RINm5F
and isolated rat islets
Crude cell and nuclear extracts from leptin-treated
RINm5F cells were probed with an anti-phospho-
Y705 STAT3 antibody. Leptin produced a time-
dependent tyrosine phosphorylation and nuclear
translocation of two immunoreactive STAT3
species (Fig. 3a). The rapidly induced more slowly
migrating band at approximately 90 kDa is consist-
ent with STAT3Æ. The faster migrating band is
consistent with STAT3â and was induced by
15 min in crude RINm5F cell extracts. This
suggests diVerential activation of the two isoforms
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in response to leptin in the cytosol and subsequent
nuclear translocation in RINm5F cells. Low levels
of STAT3â could be detected after leptin treatment
in nuclear extracts of RINm5F cells by 30 min upon
longer exposure of the blots (data not shown).
Leptin caused nuclear activation of STAT3Æ over
the concentration range 0·2–200 nM in RINm5F
but STAT3 activation was lost at 2 µM leptin in
RINm5F cells (Fig. 3b). Leptin treatment of
isolated rat pancreatic islets produced an increase in
tyrosine phosphorylated STAT3 that peaked by
15 min and dropped to basal levels by 30 min in
crude islet extracts (Fig. 4, upper gel and graph).
The increase in STAT3Æ and STAT3â tyrosine
phosphorylation was significantly greater at 15 min
than at the 0 time point as normalized to the level
of STAT3 detected with an N-terminal-directed
STAT3 antibody (Fig. 4 lower gel). (The increase
compared with 100% at 0 time point was: STAT3Æ,
650&110%, P<0·02, n=4; STAT3â, 487&126%,
P<0·05, n=4.) The reference sample in the lower gel
of Fig. 4 is from an A431 cell lysate commercially
provided as a positive control for STAT3 detection.
Leptin induces transcriptional activation
from STAT consensus elements transfected
into RINm5F cells
Leptin increased transcriptional activation from
reporter plasmids containing GAS (from the FcªRI
promoter) and IRE (from the human ICAM-1
promoter) STAT-binding elements (Fig. 5). Leptin-
induced transcriptional activity was greater with the
IRE (which has a higher aYnity for STAT3)
compared with the GAS construct (which has a
higher aYnity for STAT1) consistent with STAT3
activation (Caldenhoven et al. 1995). Leptin did not
induce transcriptional activation of a reporter
plasmid driven by the STAT5 consensus element,
â-CAS or the control vector, pBL (Fig. 5).
Leptin-mediated STAT DNA binding is
modulated by increases in intracellular
cAMP and [Ca2+]i
RINm5F cells were pre-incubated with a number of
eVectors designed to mimic states of increased
metabolic activity for 15 min and then in the
presence of added leptin (100 nM) for a further
15 min (Fig. 6). As before, leptin alone (100 nM)
induced DNA binding of a single STAT complex
within 15 min. Acetylcholine (10 µM), an endogen-
ous parasympathetic stimulator of insulin secretion,
caused a marked reduction in leptin-induced STAT
DNA binding to the probe. Pre-incubation of the
RINm5F cells with 100 nM phorbol 12-myristate
13-acetate (PMA), a protein kinase C (PKC)
activator, had no significant eVect on leptin-induced
STAT DNA binding, although it increased c-fos
transcript levels in RINm5F as assessed by
Northern blot (data not shown). Pre-incubation
with the calcium ionophore, ionomycin (1 µg/ml)
produced a marked attenuation of leptin-induced
STAT DNA binding. Finally, we tested the eVects
of raising intracellular cAMP by pre-incubating
figure 1. Time-dependent induction of STAT DNA
binding to the m67SIE element from the c-fos promoter
by leptin in RINm5F nuclear extracts. Cells were
pre-incubated for 36 h in serum-free medium and then
exposed to leptin (100 nM) for the time indicated below
the lanes. Nuclear extracts were isolated and run in a
DNA binding assay with end-labelled m67SIE
oligonucleotide. Protein/DNA complexes were separated
on a 5% native PAGE gel. The upper arrow indicates
the single complex induced by leptin.
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with both the adenylyl cyclase activator, forskolin
(10 µM), and the cAMP phosphodiesterase inhibi-
tor, IBMX (50 µM). This treatment resulted in a
reduction of leptin-induced STAT DNA binding
to basal levels; however, this reduction was not
as marked as that caused by acetylcholine or
ionomycin (Fig. 6).
Increasing cellular metabolic activity does
not aVect STAT3 tyrosine phosphorylation
RINm5F nuclear extracts, which had been pre-
incubated with various eVectors and then leptin
(100 nM) as described above, were probed with the
antibody to phospho-Y705 STAT3 (Fig. 7 upper
gel) and an anti-N-terminal STAT3 antibody (Fig.
7 lower gel). This revealed that leptin induced
STAT3 tyrosine phosphorylation; however, there
was no significant change in the tyrosine phos-
phorylation levels of the STAT3 in response to
any of the agents tested.
Leptin increases activated MAP kinase-Y204
levels in RINm5F cells
Nuclear extracts of leptin-treated RINm5F cells
were probed for active MAP kinase with a
phospho-Y204-MAP kinase-specific antibody. Lep-
tin caused an increase in the levels of a 44 and
42 kDa MAP kinase-immunoreactive species within
figure 2. Dose- and time-dependent induction of STAT DNA binding to
the m67SIE element from the c-fos promoter by leptin in rat islet nuclear
extracts. Islets were isolated and pre-incubated for 6 h in serum-free
RPMI-1640 and then exposed to leptin for 15 min with the leptin
concentrations indicated below the lanes (left panel) or to 20 nM leptin for
the time indicated below the lane (right panel). Nuclear extracts were then
isolated and run in a DNA binding assay with end-labelled m67SIE
oligonucleotide. Protein/DNA complexes were separated on a 5% native
PAGE gel. The arrow indicates the single complex induced by leptin.
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15 min (Fig. 8a upper gel). The same samples were
probed with an antibody that detects ERK1 and
ERK2 (anti-panERK) regardless of its activation
state (Fig. 8a lower gel). Treatment of isolated rat
islets with 20 nM leptin did not lead to an increase
in the levels of the active MAP kinase as detected by
Western blot (Fig. 8b upper gel). MAP kinase was
readily detected in these samples (Fig. 8b lower gel)
and tyrosine phosphorylation of STAT3 was
detectable in samples prepared in a similar manner
for Western analysis (Fig. 4). Treatment of rat islets
with concentrations of leptin up to 100 nM did not
result in activation of MAP kinase (data not shown).
Nuclear extracts of RINm5F from cells treated with
100 nM leptin for 15 min were used as a positive
control in the blots for potential activation of MAP
kinase by leptin in pancreatic islets (Fig. 8b).
DISCUSSION
Pancreatic â-cell failure is a hallmark of NIDDM
(Poitout & Robertson 1996). A large proportion of
patients with NIDDM are also obese (Groop &
figure 3. Time-dependent induction of tyrosine phosphorylation and nuclear
translocation of STAT3 by leptin in RINm5F nuclear extracts. (a) Cells were
pre-incubated for 36 h and then exposed to leptin (100 nM) for the time indicated
below the lanes. Leptin caused tyrosine phosphorylation of STAT3Æ (this band
migrated at approximately 90 kDa and is indicated by an arrow) by 5 min and
STAT3â by 15 min in crude cell extracts (left panel) that continued to increase
until the 30 min time point. The nuclear translocation of tyrosine phosphorylated
STAT3Æ was detected in nuclear extracts by 15 min (right panel). (b) RINm5F
cells were treated for 15 min with the concentration of leptin indicated below the
lane and the nuclear extracts isolated. Tyrosine phosphorylated nuclear STAT3Æ
was induced over the concentration range 0·2–200 nM leptin.
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figure 4. Time-dependent induction of STAT3
tyrosine phosphorylation by leptin in isolated rat islets.
Rat islets were isolated and pre-incubated for 6 h in
serum-free RPMI-1640 and then exposed to leptin (20
nM) for the times indicated above the lanes. Islets were
collected by centrifugation, immediately boiled in
sample buVer and run on 10% SDS-PAGE gels.
STAT3 was detected with an antibody to activated
(phospho-Y705) STAT3 (upper gel) and a STAT3
N-terminal-specific antibody (lower gel). The graph
shows a quantification of the time-dependent induction
of tyrosine phosphorylation of STAT3Æ and STAT3â
normalized to the 0 time levels of STAT3Æ and
STAT3â respectively. Control samples (lower gel, left)
are from A431 cell lysates. Results are expressed as
mean&s.e.m. and statistical significance determined
using Student’s unpaired t-test (*P<0·05, **P<0·02 vs 0
time point (n=4)).
figure 5. Transcriptional activation of reporter
constructs driven by STAT element promoters by leptin
in RINm5F cells. Cells were transiently transfected with
CAT reporter plasmids containing the GAS, IRE or
â-CAS STAT responsive promoter elements. Induction
of transcription was most marked from the IRE
construct and there was no activation of the
STAT5-selective construct. Also shown is the control
construct (pBL). Results are mean&s.e.m. of three
experiments.
figure 6. EVect of increasing cellular metabolic activity
on leptin-induced STAT DNA binding in
RINm5Fcells. RINm5F cells were pre-incubated for
36 h in serum-free RPMI-1640, 0·1% BSA. A second
15 min pre-incubation with the eVector indicated below
the lane was then followed by incubation of the cells
with leptin (100 nM) plus the eVector for a further
15 min. Nuclear extracts were then isolated as described
and run on 5% native PAGE gels with the end-labelled
m67SIE probe. The eVectors used were acetylcholine
(10 µM), PMA (100 nM), ionomycin (1 µg/ml) and
forskolin (10 µM)/IBMX (50 µM).
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Tuomi 1997) and all are insulin resistant. NIDDM
develops when compensatory hyperinsulinaemia
fails to overcome the insulin resistance. We have
suggested previously that the high levels of leptin
found in obesity might be one of the factors that
precipitates NIDDM through its inhibitory action
on the â-cell (Emilsson et al. 1997, Pallett et al.
1997). We and others have demonstrated that leptin
could cause inhibition of insulin secretion from
mouse and rat islets (Chen et al. 1997, Emilsson
et al. 1997, Fehmann et al. 1997a, KieVer et al.
1997, Kulkarni et al. 1997, Pallett et al. 1997,
Ookooma et al. 1998, Poitout et al. 1998) and a
reduction in insulin transcript levels in rat islets
(Kulkarni et al. 1997, Pallett et al. 1997). This
phenomenon has been shown to involve leptin-
mediated activation of the ATP-sensitive potassium
channels in islets (KieVer et al. 1997) and
insulin-secreting cell lines (Harvey et al. 1997) and a
reduction in [Ca2+]i in islets (Fehmann et al. 1997a,
KieVer et al. 1997) and insulin-secreting cell lines
(Fehmann et al. 1997a,b). Inhibition of insulin
secretion has also been observed in vivo in
normal-fed mice and with human islets exposed
to physiological levels of leptin in vitro (Kulkarni
et al. 1997). Furthermore, chronic leptin exposure
leads to islet triglyceride depletion and a loss of
nutrient-induced insulin secretion in vivo and
in vitro (Koyama et al. 1997, Shimabukuro et al.
1997, Wang et al. 1998). Taken together, this
evidence suggests that leptin may have a physiologi-
cal influence on the normal glucose-sensing mech-
anism of the pancreatic â-cell. However, it is also
clear that many obese subjects with high circulating
figure 7. EVect of agents that modulate leptin-induced
STAT DNA binding on STAT3 tyrosine
phosphorylation. RINm5F cells were pre-incubated for
36 h in serum-free RPMI-1640, 0·1% BSA. A second
15 min pre-incubation with the eVector indicated below
the lane was then followed by incubation with leptin
(100 nM) plus the eVector for a further 15 min. Nuclear
extracts were isolated and subjected to Western blot and
probed with an antibody to activated (Y705) STAT3
(upper gel) and a STAT3 N-terminal-specific antibody
(lower gel). The eVectors used were acetylcholine
(10 µM), PMA (100 nM), ionomycin (1 µg/ml) and
forskolin (10 µM)/IBMX (50 µM).
figure 8. Time-dependent induction of MAP kinase
p42 and p44 tyrosine phosphorylation by leptin in
RINm5F cells but not in rat islets. (a) RINm5F cells
were pre-incubated for 36 h in serum-free RPMI-1640,
0·1% BSA and then leptin (100 nM) for the time
indicated above the lane. Nuclear extracts were then run
on 10% SDS-PAGE gels, transferred to PVDF and
probed with an antibody to activated (Y204) MAP
kinase (upper gel) and an anti-panERK (lower gel)
antibody. Leptin caused an increase in the tyrosine
phosphorylated MAP kinases that was detectable by
15 min and dropped by 30 min of incubation. (b)
Isolated rat islets were pre-incubated for 6 h and then
exposed to leptin (20 nM) for the times indicated above
the lane. Crude protein extracts were then probed with
the (Y204) MAP kinase (upper gel) and anti-panERK
(lower gel) antibodies. The arrows indicate the apparent
molecular masses of the bands. Nuclear extracts of
RINm5F from cells treated with 100 nM leptin for
15 min were used as positive control in the blots for the
potential activation of MAP kinase by leptin in
pancreatic islets.
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leptin concentrations are not diabetic and animal
studies show that exogenously administered leptin
generally improves insulin action in obese animals.
Thus it seems that the potential diabetogenic
activity of leptin is modified by diVerential eYcacy
of the leptin signalling pathways in various tissues.
The role of leptin signalling through OB-Rb in the
long-term control of pancreatic â-cell metabolism
and gene expression (â-cell programming) is
currently unclear.
The full-length leptin receptor, OB-Rb (Chen
et al. 1996), is closely related to the type I
superfamily of cytokine receptors (Tartaglia et al.
1995). OB-Rb is known to homodimerize (White et
al. 1997) and to activate JAK2 (Ghilardi & Skoda
1997) and STATs 1, 3 and 5B (Baumann et al.
1996) or 3, 5 and 6 (Ghilardi et al. 1996) in in vitro
overexpression systems. In vivo, the activation
pattern appears more restricted. Indeed, despite the
availability of STATs 1, 3, 5 and 6, leptin appears
to activate only STAT3 in the hypothalamus
(Vaisse et al. 1996), STAT1 in adipose tissue
(Siegrist-Kaiser et al. 1997) and STAT5 in the
small intestine (Morton et al. 1998). We find that
leptin activates STAT3 in isolated rat islets where
approximately 80% of the cell population are â-cells
(Orci 1986). A STAT3 signalling mechanism in the
â-cell is corroborated by activation of STAT3 in
nuclear extracts of RINm5 cells, a rat clonal
pancreatic â-cell model that we have shown
previously responds to leptin and expresses high
levels of OB-Rb (Islam et al. 1997). Although
STAT1 and 5 were detected in both isolated rat
islets and RINm5F, we did not detect activation of
either molecule in response to leptin treatment by
probing with a specific antibody to phospho-Y701
STAT1 or using a STAT5-selective â-casein
oligonucleotide (data not shown). We also did not
detect transcriptional activation of a reporter
construct linked to the â-casein element. It is
therefore likely that the leptin signal is transmitted
by diVerent STATs depending on the target tissue,
time frame and cellular system under study. We also
show that leptin can cause induction of transcription
from reporter constructs with STAT3-responsive
promoter elements in RINm5F. This indicates that
STAT3 activation leads directly to transcriptional
activation and provides evidence of the first stages
of â-cell programming by leptin through STAT3.
The time-course for induction of STAT3Æ and
STAT3â appears to be more rapid in the primary
islet compared with the RINm5F cell. This may be
relevant for the kinetics of gene activation in
primary â-cells versus clonal â-cells. The delayed
activation and nuclear translocation of STAT3â
seen in RINm5F cells may also have important
consequences, since STAT3Æ and STAT3â are
reported to have diVerent functional roles in
controlling gene expression (Caldenhoven et al.
1996, SchaeVer et al. 1997). The concentrations of
leptin that elicit STAT activation fall within the
physiological range (MaVei et al. 1995). Thus,
induction of STAT DNA binding is detectable in
isolated rat islet nuclear extracts with 2 nM leptin
and STAT3 activation is observed at concentrations
as low as 0·2 nM leptin in RINm5F nuclear
extracts. This supports a role for leptin in
modulation of â-cell function under normal physio-
logical conditions. An extreme concentration (2 µM)
of leptin led to a loss of nuclear STAT3 activation
as assessed by Western blot and may represent
saturation of leptin receptor binding as we found
previously for the U-shaped dose-dependent inhi-
bition of insulin secretion (Pallett et al. 1997).
The insulin synthesis and secretory mechanism of
the pancreatic â-cell are controlled by membrane
depolarization and calcium influx due to nutrient
metabolism (Prentki et al. 1997). This process is
potentiated by hormone-mediated elevation of
intracellular second messengers such as cAMP
(Amma¨la¨ et al. 1993, Holz et al. 1993) and
d-myo-inositol 1,4,5-trisphosphate (IP3) (Zawalich
& Zawalich 1996). We have assessed the impact of
increased metabolic activity on leptin-inducible
STAT DNA binding activity and STAT3 tyrosine
phosphorylation in a clonal insulin-secreting cell
line that we had found to respond functionally to
leptin (Islam et al. 1997). Although RINm5F cells
lack the cellular machinery that allows them to
respond to glucose (Praz et al. 1983), these cells
retain many of the features of regulated insulin
release and have been used extensively as a model of
the pancreatic â-cell. The lack of glucose respon-
siveness in the RINm5F cells was circumvented by
experimental approaches using pharmacological
agents that mimic the raised metabolic activity
found in native â-cells upon exposure to glucose
and hormonal stimuli. Increased [Ca2+]i is known to
be one of the major events that occurs after the
exposure of normal â-cells to stimulatory concen-
trations of nutrients, primarily glucose, and hormo-
nal stimuli (Zawalich & Zawalich 1996, Gromada
et al. 1997, Prentki et al. 1997). Raising [Ca2+]i with
the calcium ionophore ionomycin leads to a marked
reduction in leptin-inducible STAT DNA binding
to the m67SIE probe. This could be interpreted as
evidence that raised metabolic activity attenuates
leptin signalling in â-cells and is consistent with a
counteraction of the reduction of [Ca2+]i ascribed to
leptin (Fehmann et al. 1997a, KieVer et al. 1997,
Kulkarni et al. 1997). It should be noted, however,
that raising intracellular calcium with ionomycin
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does not allow discrimination between extracellular
and intracellular sources of calcium. We also
exposed RINm5F to forskolin and IBMX, com-
pounds that activate adenylyl cyclase and inhibit
cAMP phosphodiesterases respectively. These
agents raise intracellular cAMP, a second messenger
that can potentiate insulin secretion (Ammo¨lo¨ et al.
1993, Holz et al. 1993, Gromada et al. 1997). The
RINm5F cell has been reported to secrete insulin in
response to increased cAMP through a calcium-
independent mechanism (Wollheim et al. 1984),
whereas intact rat â-cells exhibit calcium-dependent
cAMP-inducible insulin secretion (Holz et al.
1993). Increasing cAMP resulted in a reduction of
leptin-induced STAT DNA binding to basal levels
in RINm5F cell nuclear extracts. Since the cAMP
response in RINm5F is believed to be uncoupled
from increased [Ca2+]i, this could imply a role for
cAMP-dependent protein kinase (PKA) in negative
modulation of leptin signalling. Agents that raise
â-cell metabolic activity by this mechanism, such as
the insulinotropic hormone, GLP-1, may counter-
act leptin signalling by a combined increase in PKA
activity and raised [Ca2+]i in native rat â-cells (Holz
et al. 1993, Gromada et al. 1997). Reversal of
leptin-mediated inhibition of insulin secretion by
GLP-1 has also been observed (Fehmann et al.
1997b). The activation of calcium-dependent pro-
tein kinases (PKCs) is another event associated with
increased metabolic activity in â-cells. Glucose
metabolism (Easom et al. 1989) and exposure of the
â-cell to stimuli such as the parasympathetic
neurotransmitter, acetylcholine (Zawalich &
Zawalich 1996), lead to increased activation of
PKC, increased [Ca2+]i and an increase in insulin
secretion. We exposed RINm5F cells to both the
PKC agonist, PMA, and acetylcholine. Activation
of PKC alone did not aVect leptin-inducible STAT
DNA binding. In contrast, acetylcholine caused a
marked reduction in leptin-induced STAT DNA
binding that could be due to the rapid increase in
intracellular calcium released from internal stores in
response to production of the second messenger,
IP3, by this neurotransmitter (Zawalich & Zawalich
1996). The lack of eVect of direct PKC activation by
PMA on STAT DNA binding indicates that a
PKC-linked mechanism of raising intracellular
calcium, as has been described in RINm5F cells
(Yada et al. 1989), does not contribute to a
reduction in leptin-inducible STAT DNA binding
in this cell line under the conditions tested. The
present information supports a role for raised
intracellular calcium, as opposed to direct action of
PKC in the attenuation of leptin-mediated STAT
DNA binding activity. This does not, however, rule
out modulation of STAT3 activation through a
PKC-mediated change in serine phosphorylation as
has been reported by others to occur (Yang et al.
1996). The leptin-deficient ob/ob mouse is charac-
terized by hyperinsulinaemia due to an exaggerated
PKC-linked sensitivity at the â-cell level (Chen &
Romsos 1997) that can be ‘corrected’ by leptin
treatment of ob/ob islets (Chen et al. 1997).
Increased parasympathetic stimuli or exposure to
other hormones that act through raising intracellu-
lar calcium (for example cholecystokinin and
vasopressin) are therefore also likely to counteract
OB-Rb-mediated signalling in the â-cell. Attenu-
ation of the inhibitory programming of the â-cell
by leptin could therefore contribute to the hyper-
insulinaemia associated with a raised parasympa-
thetic tone found in some forms of obesity (Bray
et al. 1990). We did not detect any change in
tyrosine phosphorylation of STAT3 in response to
any of the eVectors tested. This implies that events
downstream of STAT activation by JAKs are a
target for modulation by these agents.
We have also recently found that leptin can
induce the immediate-early gene, c-fos, in RINm5F
and that this precedes a proliferative response
(Islam et al. 1997). A similar MAP kinase-
dependent eVect has subsequently been observed in
the MIN-6 â-cell line (Tanabe et al. 1997). In the
current studies we find a leptin-mediated increase
in the levels of active MAP kinase isoforms in
RINm5F cells but not in adult primary rat islets.
One interpretation of these data is that leptin may
have a role in controlling the early development and
growth/diVerentiation of islet â-cells in discrete
sub-populations. We proposed previously that high
levels of leptin might contribute to the â-cell
hyperplasia and hypertrophy associated with obesity
by aVecting this process in some way (Islam et al.
1997). Alternatively, activation of MAP kinase
activity in â-cells may be involved in the
modulation of STAT signalling. Thus, MAP kinase
is known to serine phosphorylate STAT3 leading to
a modulation of its DNA-binding activity (Chung
et al. 1997).
The present study implicates signalling through
STAT3 as a likely mechanism whereby regulation
of gene expression in the â-cell is modulated by
leptin. STAT3 activation has been associated with
diverse phenomena such as cell transformation
(Karras et al. 1997, Turkson et al. 1998) and
diVerentiation (Minami et al. 1996) and is also the
target for leptin action in the hypothalamus in vivo
(Vaisse et al. 1996). The sub-set of target genes
under the influence of leptin-inducible STAT3 in
â-cells is therefore an important area of future
study. Leptin-mediated proliferation of clonal
â-cells (Islam et al. 1997, Tanabe et al. 1997) and
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cells of haematopoietic origin (Gainsford et al. 1996)
associated with MAP kinase activity have also been
described. However, since we did not find a similar
activation of MAP kinase in isolated rat islets, this
could mean that MAP kinase is not a major pathway
involved in the regulation of primary â-cell function
by leptin. Finally, our observation that raising
intracellular calcium and cAMP interferes with
leptin signalling suggests that raised metabolic
activity may counteract leptin-inducible DNA
binding of STAT3 in the â-cell. Since leptin may
have a physiological inhibitory role in the regulation
of â-cell responses to nutrients and other stimuli,
chronic hyperglycaemia, inappropriate hormonal
stimuli or insensitivity to leptin action such as that
found in obese individuals could contribute to
hyperinsulinaemia at early stages in the transition
from obesity to NIDDM. Subsequently, perhaps
during conditions of â-cell glucose desensitization
and glucose toxicity, as is postulated to occur in
NIDDM (Poitout & Robertson 1996), the high
plasma leptin levels in obese individuals may
become diabetogenic.
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